Impact of changes in tricuspid regurgitation on clinical outcomes following mitral valve teer compared to guideline-directed medical therapy: a sub-analysis of the COAPT trial

Back

EACVI Premium Access

Impact of changes in tricuspid regurgitation on clinical outcomes following mitral valve teer compared to guideline-directed medical therapy: a sub-analysis of the COAPT trial

Session: New insights into the challenging tricuspid valve

Topic: Valvular Heart Disease

Speaker: Doctor K. Lehenbauer (New York, US)

Event: EuroEcho 2021

Congress Presentation

Add to my library

About the speaker

Doctor Kyle Lehenbauer

Columbia University Medical Centre, New York (United States of America)

0 follower

6 more presentations in this session

The five phenotypes of tricuspid regurgitation: insight from cluster analysis of clinical and echocardiographic variables

Speaker: Doctor V. Anand (Rochester, US)

Impact of leaflet-tethering angle correction on the assessment of tricuspid regurgitation severity using the PISA method

Speaker: Doctor M. Tomaselli (Milan, IT)

Intracardiac device associated interference with tricuspid valve apparatus on echocardiography: What can we learn from pathology?

Speaker: Doctor M. Henry (Chicago, US)

Characterization of coaptation gap in patients receiving tricuspid transcatheter edge-to-edge repair: initial observations from the bRIGHT TriClip study

Speaker: Doctor E. Donal (Rennes, FR)

Effect of interventional edge-to-edge repair in tricuspid regurgitation on dimensions of the annulus

Speaker: Doctor B. Goebel (Bad Berka, DE)

Access the full session

New insights into the challenging tricuspid valve

Speakers: Doctor K. Lehenbauer, Doctor V. Anand, Doctor M. Tomaselli, Doctor M. Henry, Doctor E. Donal...

Access

About the event

EuroEcho 2021

9 December - 11 December 2021

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources